Listed

Functional Brands Inc.

MEHAOTCCIK 1837254HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$1.9mRevenue, Q2 FY2026, three months to 2026-06-30$1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 14, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$1.9mRevenue, Q2 FY2026, three months to 2026-06-30$1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure+2.1% on a year earlier
  • Gross margin59.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $1.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Revenue: $1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure+7.1 pts on a year earlier
  • Operating margin−70.6%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Revenue: $1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure−62.1 pts on a year earlier
  • Net margin−140.6%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Revenue: $1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure−128.3 pts on a year earlier
  • Diluted EPS−$0.06Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure−100.0% on a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$1.9mGross margin 59.9%
Diluted EPS−$0.06, Q2 FY2026
Free cash flow−$2.7m, Q4 FY2025
Functional Brands Inc., key figures for the last eight quarters
Line itemUnitperiod not labelled2024-09-30period not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k1,396Revenue, period not labelled, three months to 2024-09-30$1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figure1,680Revenue, period not labelled, three months to 2024-12-31$1.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figure1,590Revenue, period not labelled, three months to 2025-03-31$1.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure1,833Revenue, period not labelled, three months to 2025-06-30$1.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure1,694Revenue, Q3 FY2025, three months to 2025-09-30$1.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figure1,495Revenue, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figure1,646Revenue, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure1,871Revenue, Q2 FY2026, three months to 2026-06-30$1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure
Gross margin%54.7%Gross margin, period not labelled, three months to 2024-09-30. gross profit / revenueGross profit: $763.7k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Revenue: $1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figure58.9%Gross margin, period not labelled, three months to 2024-12-31. gross profit / revenueGross profit: $989.5k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Revenue: $1.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figure54.5%Gross margin, period not labelled, three months to 2025-03-31. gross profit / revenueGross profit: $866.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Revenue: $1.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure52.8%Gross margin, period not labelled, three months to 2025-06-30. gross profit / revenueGross profit: $968.1k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Revenue: $1.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure57.7%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $978.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Revenue: $1.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figure44.9%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $670.8k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Revenue: $1.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figure58.4%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $961.1k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Revenue: $1.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure59.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $1.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Revenue: $1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure
Operating margin%(15.7%)Operating margin, period not labelled, three months to 2024-09-30. operating income / revenueOperating income: −$218.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Revenue: $1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figure(8.1%)Operating margin, period not labelled, three months to 2024-12-31. operating income / revenueOperating income: −$135.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Revenue: $1.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figure(2.0%)Operating margin, period not labelled, three months to 2025-03-31. operating income / revenueOperating income: −$32.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Revenue: $1.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure(8.5%)Operating margin, period not labelled, three months to 2025-06-30. operating income / revenueOperating income: −$155.4k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Revenue: $1.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure(4.6%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$78.3k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Revenue: $1.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figure(75.8%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Revenue: $1.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figure(41.5%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$682.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Revenue: $1.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure(70.6%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Revenue: $1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure
Net margin%(20.6%)Net margin, period not labelled, three months to 2024-09-30. net income / revenueNet income: −$288.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Revenue: $1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figure(16.5%)Net margin, period not labelled, three months to 2024-12-31. net income / revenueNet income: −$277.8k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Revenue: $1.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figure(8.0%)Net margin, period not labelled, three months to 2025-03-31. net income / revenueNet income: −$126.8k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Revenue: $1.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure(12.3%)Net margin, period not labelled, three months to 2025-06-30. net income / revenueNet income: −$226.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Revenue: $1.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure15.3%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $259.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Revenue: $1.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figure57.0%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $852.3k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Revenue: $1.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figure(424.8%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Revenue: $1.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure(140.6%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Revenue: $1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure
Diluted EPS$ per share(0.04)Diluted EPS, period not labelled, three months to 2024-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figurenot reported (Diluted EPS not reported)(0.02)Diluted EPS, period not labelled, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure(0.03)Diluted EPS, period not labelled, three months to 2025-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure0.04Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-15, accession 0001213900-25-121689.Report this figurenot reported (Diluted EPS not reported)(0.36)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-057934.Report this figure(0.06)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-089996.Report this figure
Free cash flow$knot reported (Operating cash flow and Capital expenditure not reported)56.2Free cash flow, period not labelled, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $56.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)(2,750)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001213900-26-035675. Derived: 12-month figure less the 9-month figure.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$6.6mGross margin 52.7%
Diluted EPS$0.01, FY2025
Free cash flow−$1.3m, FY2025
Functional Brands Inc., key figures for the last five fiscal years
Line itemUnitFY2024-12-31FY20252025-12-31Shape over the periods
Revenue$k6,566Revenue, period not labelled, twelve months to 2024-12-31$6.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure6,611Revenue, FY2025, twelve months to 2025-12-31$6.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure
Gross margin%54.9%Gross margin, period not labelled, twelve months to 2024-12-31. gross profit / revenueGross profit: $3.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001213900-26-035675.Revenue: $6.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure52.7%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $3.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001213900-26-035675.Revenue: $6.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure
Operating margin%(3.5%)Operating margin, period not labelled, twelve months to 2024-12-31. operating income / revenueOperating income: −$229.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035675.Revenue: $6.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure(21.2%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035675.Revenue: $6.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure
Net margin%(8.5%)Net margin, period not labelled, twelve months to 2024-12-31. net income / revenueNet income: −$559.4k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035675.Revenue: $6.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure11.5%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $758.5k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035675.Revenue: $6.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure
Diluted EPS$ per share(0.08)Diluted EPS, period not labelled, twelve months to 2024-12-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure0.01Diluted EPS, FY2025, twelve months to 2025-12-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure
Free cash flow$k0.1Free cash flow, period not labelled, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $2.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001213900-26-035675.Capital expenditure: $1.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure(1,280)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001213900-26-035675.Capital expenditure: $8.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001213900-26-035675.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Functional Brands Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Guardian Partners Inc.2026-06-30$20338,972New+38,972

Recent filings

All 114 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Functional Brands Inc., recent filings
FiledFormWhat it isAccession number
2026-08-1716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-26-090736
2026-08-1416:01 ET10-QQuarterly reportPeriod 2026-06-300001213900-26-089996
2026-07-0216:16 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-26-074986
2026-07-0118:46 ET8-K1.02 Termination of a material agreement0001213900-26-073885
2026-06-1508:00 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-068518
2026-06-0218:08 ET8-K5.07 Shareholder vote results0001213900-26-063630
2026-05-2808:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-26-061761
2026-05-2210:14 ET8-K/A5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-26-060362
2026-05-2209:06 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-060328
2026-05-2017:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-26-059603

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 27, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1837254
Tickers
MEHA
Exchange
OTC
SIC code
2833 Medicinal Chemicals & Botanical Products
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
<br>Emerging growth company
Former names
HT Naturals Corp. (to 2023-05-02)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.